Terms: = Lung cancer AND KDM5A, RBBP2, 5927, JARID1A, ENSG00000073614
15 results:
1. Evaluate the Prognosis of
Cao J; J Gu J; Liang Y; Wang B
Technol Cancer Res Treat; 2022; 21():15330338221138213. PubMed ID: 36524293
[No Abstract] [Full Text] [Related]
2. The molecular characteristics of high-grade gastroenteropancreatic neuroendocrine neoplasms.
Venizelos A; Elvebakken H; Perren A; Nikolaienko O; Deng W; Lothe IMB; Couvelard A; Hjortland GO; Sundlöv A; Svensson J; Garresori H; Kersten C; Hofsli E; Detlefsen S; Krogh M; Sorbye H; Knappskog S
Endocr Relat Cancer; 2021 Nov; 29(1):1-14. PubMed ID: 34647903
[TBL] [Abstract] [Full Text] [Related]
3. Histone demethylase kdm5a enhances cell proliferation, induces EMT in lung adenocarcinoma cells, and have a strong causal association with paclitaxel resistance.
Xu L; Wu H; Hu X
Acta Biochim Pol; 2021 Jul; 68(4):593-602. PubMed ID: 34270886
[TBL] [Abstract] [Full Text] [Related]
4. Extended Recognition of the Histone H3 Tail by Histone Demethylase kdm5a.
Petronikolou N; Longbotham JE; Fujimori DG
Biochemistry; 2020 Feb; 59(5):647-651. PubMed ID: 31985200
[TBL] [Abstract] [Full Text] [Related]
5. The kdm5a/RBP2 histone demethylase represses NOTCH signaling to sustain neuroendocrine differentiation and promote small cell lung cancer tumorigenesis.
Oser MG; Sabet AH; Gao W; Chakraborty AA; Schinzel AC; Jennings RB; Fonseca R; Bonal DM; Booker MA; Flaifel A; Novak JS; Christensen CL; Zhang H; Herbert ZT; Tolstorukov MY; Buss EJ; Wong KK; Bronson RT; Nguyen QD; Signoretti S; Kaelin WG
Genes Dev; 2019 Dec; 33(23-24):1718-1738. PubMed ID: 31727771
[TBL] [Abstract] [Full Text] [Related]
6. Identification of ryuvidine as a kdm5a inhibitor.
Mitsui E; Yoshida S; Shinoda Y; Matsumori Y; Tsujii H; Tsuchida M; Wada S; Hasegawa M; Ito A; Mino K; Onuki T; Yoshida M; Sasaki R; Mizukami T
Sci Rep; 2019 Jul; 9(1):9952. PubMed ID: 31289306
[TBL] [Abstract] [Full Text] [Related]
7. The cancer driver genes IDH1/2, JARID1C/ KDM5C, and UTX/ KDM6A: crosstalk between histone demethylation and hypoxic reprogramming in cancer metabolism.
Chang S; Yim S; Park H
Exp Mol Med; 2019 Jun; 51(6):1-17. PubMed ID: 31221981
[TBL] [Abstract] [Full Text] [Related]
8. Identification of ortho-hydroxy anilide as a novel scaffold for lysine demethylase 5 inhibitors.
Jaikhan P; Buranrat B; Itoh Y; Chotitumnavee J; Kurohara T; Suzuki T
Bioorg Med Chem Lett; 2019 May; 29(10):1173-1176. PubMed ID: 30928196
[TBL] [Abstract] [Full Text] [Related]
9. Schwann Cells Augment Cell Spreading and Metastasis of lung cancer.
Zhou Y; Shurin GV; Zhong H; Bunimovich YL; Han B; Shurin MR
Cancer Res; 2018 Oct; 78(20):5927-5939. PubMed ID: 30135194
[TBL] [Abstract] [Full Text] [Related]
10. Targeted next generation sequencing identified clinically actionable mutations in patients with esophageal sarcomatoid carcinoma.
Lu H; Yang S; Zhu H; Tong X; Xie F; Qin J; Han N; Wu X; Fan Y; Shao YW; Mao W
BMC Cancer; 2018 Mar; 18(1):251. PubMed ID: 29506494
[TBL] [Abstract] [Full Text] [Related]
11. Tungsten exposure causes a selective loss of histone demethylase protein.
Laulicht-Glick F; Wu F; Zhang X; Jordan A; Brocato J; Kluz T; Sun H; Costa M
Mol Carcinog; 2017 Jul; 56(7):1778-1788. PubMed ID: 28218462
[TBL] [Abstract] [Full Text] [Related]
12. Screen-identified selective inhibitor of lysine demethylase 5A blocks cancer cell growth and drug resistance.
Gale M; Sayegh J; Cao J; Norcia M; Gareiss P; Hoyer D; Merkel JS; Yan Q
Oncotarget; 2016 Jun; 7(26):39931-39944. PubMed ID: 27224921
[TBL] [Abstract] [Full Text] [Related]
13. Registered report: A chromatin-mediated reversible drug-tolerant state in cancer cell subpopulations.
Haven B; Heilig E; Donham C; Settles M; Vasilevsky N; Owen K; ;
Elife; 2016 Feb; 5():. PubMed ID: 26905833
[TBL] [Abstract] [Full Text] [Related]
14. Histone demethylase RBP2 promotes lung tumorigenesis and cancer metastasis.
Teng YC; Lee CF; Li YS; Chen YR; Hsiao PW; Chan MY; Lin FM; Huang HD; Chen YT; Jeng YM; Hsu CH; Yan Q; Tsai MD; Juan LJ
Cancer Res; 2013 Aug; 73(15):4711-21. PubMed ID: 23722541
[TBL] [Abstract] [Full Text] [Related]
15. Hypoxia induces trimethylated H3 lysine 4 by inhibition of jarid1a demethylase.
Zhou X; Sun H; Chen H; Zavadil J; Kluz T; Arita A; Costa M
Cancer Res; 2010 May; 70(10):4214-21. PubMed ID: 20406991
[TBL] [Abstract] [Full Text] [Related]
